ATD Bioseek

TIDMATD

RNS Number : 6273B

Asterand PLC

19 April 2012

19 April 2012

ASTERAND PLC

('Asterand' or 'the Company')

Notification of Final Results

Date: Monday 30 April 2012

Asterand plc ("Asterand" or the "Group" - LSE: ATD), a leading supplier of human tissue based solutions to pharmaceutical and biotechnology companies engaged in drug discovery research will announce its Final Results for the year ended 31 December 2011, on Monday 30 April 2012.

- Ends -

Contacts:

 
Asterand plc 
Jack Davis, Chairman and Interim Chief  Tel: + 44 (0) 1763 211 600 / 
 Executive Officer                       + 1 (313) 263-0960 
Alan Fishman, Interim Chief Financial   As above 
 Officer 
 
Daniel Stewart & Company plc 
Antony Legge                            Tel: +44 (0) 20 7776 6566 
 

About Asterand

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information, go to www.asterand.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORQVLFFLZFLBBD

Bioseek (LSE:ATD)
Historical Stock Chart
From Apr 2024 to May 2024

Bioseek (LSE:ATD)
Historical Stock Chart
From May 2023 to May 2024